Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | HCG2P7 |
Upstream (Parents) |
---|
(<<) CLPS → HCG2P7 |
(<<) MYT1L → HCG2P7 |
(<<) FCGR1A → HCG2P7 |
(<<) CYP19A1 → HCG2P7 |
(<<) MYO1A → HCG2P7 |
(<<) GNG13 → HCG2P7 |
(<<) GPR135 → HCG2P7 |
(<<) CD55 → HCG2P7 |
(<<) TMEM106C → HCG2P7 |
Downstream (Children) |
---|
HCG2P7 → MYT1L (>>) |
HCG2P7 → CYP19A1 (>>) |
HCG2P7 → GNG13 (>>) |